With contributions from leading experts, this book is the first to focus solely on addressing the problems and reviewing the strategies currently being used to improve the delivery of antisense nucleic acids. Important delivery issues, such as improving biological stability, improving cell-specific targeting and cellular uptake, manipulating subcellular distribution and producing liposomal delivery systems for antisense agents are comprehensively covered in this volume.
With contributions from leading experts, this book is the first to focus solely on addressing the problems and reviewing the strategies currently being used to improve the delivery of antisense nucleic acids. Important delivery issues, such as improving biological stability, improving cell-specific targeting and cellular uptake, manipulating subcellular distribution and producing liposomal delivery systems for antisense agents are comprehensively covered in this volume.
1. Preface 2. Overview of antisense oligonucleotide therapeutics and delivery 3. Disrupting the flow of genetic information with antisense oligodeoxynucleotides: research and therapeutic applications 4. Cellular delivery of ribozymes 5. Improved structural design and cellular 6. Uptake of gt-rich triplex-forming oligonucleotides 7. Pharmacokinetic and distribution studies 8. Pharmacokinetics and delivery of oligonucleotides to the brain 9. In vivo pharmacokinetics of oligonucleotides following administration by different routes 10. Improving biological stability of oligonucleotides 11. Nuclease-resistant nucleic acid therapeutics 12. Self-stabilized oligonucleotides as novel antisense agents 13. Circular oligonucleotides as potential modulators of gene expression 14. Peptide nucleic acids as antisense therapeutic agents 15. Stabilized rna analogues for antisense and ribozyme applications 16. Improving membrane transport and targeted delivery of antisense oligonucleotides 17. Uptake and localization of phosphodeister and chimeric 18. Oligodeoxynucleotides in normal and leukaemic primary cells 19. Oligonucleotide transport across membranes and into cells: effects of chemical modifications 20. Liposomes as a delivery system for antisense and ribozyme compounds 21. Intracellular delivery of oligonucleotides with cationic liposomes 22. The delivery of oligonucleotides using ph-sensitive liposomes 23. Enhancing endsosomal exit of nucleic acids using ph-sensitive viral fusion peptides 24. Targeted delivery of anti-hepatitis b antisense oligonucleotides 25. Design, synthesis, and cellular delivery of antibody antisense oligonucleotide conjugates for cancer therapy
1. Preface 2. Overview of antisense oligonucleotide therapeutics and delivery 3. Disrupting the flow of genetic information with antisense oligodeoxynucleotides: research and therapeutic applications 4. Cellular delivery of ribozymes 5. Improved structural design and cellular 6. Uptake of gt-rich triplex-forming oligonucleotides 7. Pharmacokinetic and distribution studies 8. Pharmacokinetics and delivery of oligonucleotides to the brain 9. In vivo pharmacokinetics of oligonucleotides following administration by different routes 10. Improving biological stability of oligonucleotides 11. Nuclease-resistant nucleic acid therapeutics 12. Self-stabilized oligonucleotides as novel antisense agents 13. Circular oligonucleotides as potential modulators of gene expression 14. Peptide nucleic acids as antisense therapeutic agents 15. Stabilized rna analogues for antisense and ribozyme applications 16. Improving membrane transport and targeted delivery of antisense oligonucleotides 17. Uptake and localization of phosphodeister and chimeric 18. Oligodeoxynucleotides in normal and leukaemic primary cells 19. Oligonucleotide transport across membranes and into cells: effects of chemical modifications 20. Liposomes as a delivery system for antisense and ribozyme compounds 21. Intracellular delivery of oligonucleotides with cationic liposomes 22. The delivery of oligonucleotides using ph-sensitive liposomes 23. Enhancing endsosomal exit of nucleic acids using ph-sensitive viral fusion peptides 24. Targeted delivery of anti-hepatitis b antisense oligonucleotides 25. Design, synthesis, and cellular delivery of antibody antisense oligonucleotide conjugates for cancer therapy
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826
